Skip to Content

Association of American Medical Colleges Tomorrow's Doctors, Tomorrow's Cures®

Filter by:



Second Opinion Podcasts

Learn about policy issues important to medical schools and teaching hospitals, with Atul Grover, M.D., Ph.D.

Research

AHRQ | FDA | NIH | NSF | PCORI | VA

Future innovations in health care and prevention require research across a full spectrum of biomedical science, from basic and translational research to implementation science and comparative effectiveness research. 

AAMC advocates for funding and appropriate regulation by major federal agencies and organizations supporting this research, including the National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ), and the Department of Veterans Affairs (VA).

Ensuring a sustainable research mission is essential to achieve long-term health priorities, develop new therapeutics and preventive measures, focus on patient-centered outcomes, and reduce health disparities. 

We also work to ensure the integrity of biomedical research, especially research involving human subjects, including privacy protections and management of financial conflicts of interest.

Related

Comparative EffectivenessResponsible Conduct of Research
Research with AnimalsStem Cell Research and Regenerative Medicine

News and Updates


House Panel Reviews Revised 21st Century Cures Draft

May 1, 2015

On April 30, the one-year anniversary launch of the 21st Century Cures initiative, the House Energy and Commerce Subcommittee on Health held a hearing to review a revised discussion draft released the previous day.


Energy and Commerce Leaders Release Revised 21st Century Cures Draft

May 1, 2015

On April 30, the one-year anniversary launch of the 21st Century Cures initiative, the House Energy and Commerce Subcommittee on Health held a hearing to review a revised discussion draft released the previous day.


NIH Issues Statement Reiterating Ban on Funding Research Using Gene-Editing Technologies in Human Embryos

May 1, 2015

National Institutes of Health (NIH) Director Francis Collins, M.D., Ph.D., issued an April 29 statement affirming that the NIH will not fund any use of gene-editing technologies in human embryos.


Senate Panel Continues Examination of Medical Innovation

May 1, 2015

The Senate Health, Education, Labor, and Pensions (HELP) Committee April 28 held a hearing entitled “Continuing America’s Leadership, the Future of Medical Innovation for Patients.”


NIH to Develop Strategic Plan

May 1, 2015

National Institutes of Health (NIH) Director Francis Collins, M.D., Ph.D., told a Senate panel that the agency is “developing an overarching NIH strategic plan, and will be linking this with individual Institute/Center (IC) strategic plans that reflect the rapid current progress in bioscience.” The plan will be completed by December 2015.


On Government Affairs


Research Spectrum

Testimony and Correspondence